tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PALI Stock Latest News

Palisade Bio Approves Key Proposals at Stockholder Meeting
Company AnnouncementsPalisade Bio Approves Key Proposals at Stockholder Meeting
20d ago
8K
PALI
Palisade Bio appoints James Izanec as VP, clinical development
PremiumThe Fly
Palisade Bio appoints James Izanec as VP, clinical development
22d ago
BMY
PALI
Palisade Bio price target raised to $8 from $2 at Maxim
PremiumThe Fly
Palisade Bio price target raised to $8 from $2 at Maxim
1M ago
PALI
Palisade Bio appoints Sharon Skare as global head, clinical operations
PremiumThe Fly
Palisade Bio appoints Sharon Skare as global head, clinical operations
2M ago
PALI
Palisade Bio Terminates Phantom Unit Plan
PremiumCompany Announcements
Palisade Bio Terminates Phantom Unit Plan
2M ago
8K
PALI
Palisade Bio Approves Reverse Stock Split Amendment
PremiumCompany AnnouncementsPalisade Bio Approves Reverse Stock Split Amendment
2M ago
8K
PALI
Palisade Bio announces first patients dosed in Phase 1b study of PALI-2108
Premium
The Fly
Palisade Bio announces first patients dosed in Phase 1b study of PALI-2108
2M ago
PALI
Palisade Bio Regains Nasdaq Compliance on Stock Price
Premium
Company Announcements
Palisade Bio Regains Nasdaq Compliance on Stock Price
2M ago
8K
PALI
Palisade Bio granted Canadian patent covering PALI-2108 composition
PremiumThe Fly
Palisade Bio granted Canadian patent covering PALI-2108 composition
2M ago
PALI
Palisade Bio Cancels Stockholder Meeting Due to Quorum
PremiumCompany Announcements
Palisade Bio Cancels Stockholder Meeting Due to Quorum
3M ago
8K
PALI
Palisade Bio prices 171.4M shares at 70c in upsized underwritten public offering
PremiumThe Fly
Palisade Bio prices 171.4M shares at 70c in upsized underwritten public offering
3M ago
PALI
Palisade Bio files to sell 147.1M shares of common stock
PremiumThe Fly
Palisade Bio files to sell 147.1M shares of common stock
3M ago
PALI
Palisade Bio Adjourns Stockholder Meeting Due to Quorum
PremiumCompany AnnouncementsPalisade Bio Adjourns Stockholder Meeting Due to Quorum
3M ago
8K
PALI
Palisade Bio Reschedules Stockholder Meeting Due to Quorum Issue
Premium
Company Announcements
Palisade Bio Reschedules Stockholder Meeting Due to Quorum Issue
3M ago
8K
PALI
Optimistic Buy Rating for Palisade Bio: Promising Clinical Trials and Strategic Market Expansion
Premium
Ratings
Optimistic Buy Rating for Palisade Bio: Promising Clinical Trials and Strategic Market Expansion
3M ago
PALI
Palisade Bio reports results from PALI-2108 Phase 1b data
PremiumThe Fly
Palisade Bio reports results from PALI-2108 Phase 1b data
3M ago
PALI
Palisade Bio Launches Phantom Unit Plan for Employees
PremiumCompany Announcements
Palisade Bio Launches Phantom Unit Plan for Employees
4M ago
8K
PALI
Palisade Bio receives Health Canada clearance for Phase 1b PALI-2108 trial
PremiumThe Fly
Palisade Bio receives Health Canada clearance for Phase 1b PALI-2108 trial
4M ago
PALI
Palisade Bio releases virtual KOL Connect segment on PALI-2108
PremiumThe Fly
Palisade Bio releases virtual KOL Connect segment on PALI-2108
4M ago
PALI
Palisade Bio: Buy Rating Backed by Financial Stability and Promising Clinical Trial Results
PremiumRatingsPalisade Bio: Buy Rating Backed by Financial Stability and Promising Clinical Trial Results
4M ago
PALI
Palisade Bio files to sell 8.9M shares of common stock for holders
Premium
The Fly
Palisade Bio files to sell 8.9M shares of common stock for holders
4M ago
PALI
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
Premium
Ratings
Palisade Bio’s Strategic Positioning and Promising Trial Results Earn Buy Rating
5M ago
PALI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >